| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0304-3940(03)00295-7 |
| P698 | PubMed publication ID | 12749987 |
| P2093 | author name string | Tetsuya Maeda | |
| Toshihiro Suda | |||
| Akira Arai | |||
| Masahiko Tomiyama | |||
| Huo Shen | |||
| Kazuya Kannari | |||
| Muneo Matsunaga | |||
| P2860 | cites work | Activation of 5-HT(1A) but not 5-HT(1B) receptors attenuates an increase in extracellular dopamine derived from exogenously administered L-DOPA in the striatum with nigrostriatal denervation | Q32134305 |
| Loss of regulation by presynaptic dopamine D2 receptors of exogenous L-DOPA-derived dopamine release in the dopaminergic denervated striatum | Q42466651 | ||
| Reserpine pretreatment prevents increases in extracellular striatal dopamine following L-DOPA administration in rats with nigrostriatal denervation | Q42481642 | ||
| Fluoxetine reduces L-DOPA-derived extracellular DA in the 6-OHDA-lesioned rat striatum | Q43598286 | ||
| Sprouting of serotoninergic afferents into striatum after dopamine-depleting lesions in infant rats: a retrograde transport and immunocytochemical study | Q44362376 | ||
| Sprouting of striatal serotonin nerve terminals following selective lesions of nigro-striatal dopamine neurons in neonatal rat. | Q48222553 | ||
| Role of serotonergic neurons in L-DOPA-derived extracellular dopamine in the striatum of 6-OHDA-lesioned rats | Q48234068 | ||
| Effects of lesions of the nigrostriatal pathway and of nigral grafts on striatal serotonergic innervation in adult rats | Q48565695 | ||
| Effects of 6-hydroxydopamine lesions of the nigrostriatal pathway on striatal serotonin innervation in adult rats | Q48638093 | ||
| Serotonergic sprouting is induced by dopamine-lesion in substantia nigra of adult rat brain | Q48673694 | ||
| L-DOPA is converted to dopamine in serotonergic fibers of the striatum of the rat: a double-labeling immunofluorescence study | Q70958058 | ||
| Apparent sprouting of striatal serotonergic terminals after dopamine-depleting brain lesions in neonatal rats | Q72724643 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | striatum | Q1319792 |
| dopamine | Q170304 | ||
| P304 | page(s) | 17-20 | |
| P577 | publication date | 2003-05-01 | |
| P1433 | published in | Neuroscience Letters | Q7002625 |
| P1476 | title | Rapid induction of serotonergic hyperinnervation in the adult rat striatum with extensive dopaminergic denervation | |
| P478 | volume | 343 |
| Q36953255 | Animal models of Parkinson's disease and L-dopa induced dyskinesia: how close are we to the clinic? |
| Q48108529 | Behavioral, neurochemical and histological alterations promoted by bilateral intranigral rotenone administration: a new approach for an old neurotoxin. |
| Q41001830 | Computational studies of the role of serotonin in the basal ganglia |
| Q46546576 | Effects of coincident 5-HT1A receptor stimulation and NMDA receptor antagonism on L-DOPA-induced dyskinesia and rotational behaviors in the hemi-parkinsonian rat. |
| Q55002495 | Evidence for Sprouting of Dopamine and Serotonin Axons in the Pallidum of Parkinsonian Monkeys. |
| Q38369297 | Functional Interplay between Dopaminergic and Serotonergic Neuronal Systems during Development and Adulthood |
| Q34378866 | Glucagon signaling modulates sweet taste responsiveness. |
| Q37630366 | Increased L-DOPA-derived dopamine following selective MAO-A or -B inhibition in rat striatum depleted of dopaminergic and serotonergic innervation |
| Q38199670 | Interaction between the 5-HT system and the basal ganglia: functional implication and therapeutic perspective in Parkinson's disease. |
| Q36087200 | L-DOPA-induced dysregulation of extrastriatal dopamine and serotonin and affective symptoms in a bilateral rat model of Parkinson's disease |
| Q42224924 | Mathematical insights into the effects of levodopa |
| Q37924629 | Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation. |
| Q48212135 | Modification of L-DOPA pharmacological activity by MAO inhibitors |
| Q35165280 | Monoamine reuptake inhibitors in Parkinson's disease |
| Q48167667 | PET Imaging of Serotonin Transporters With 4-[(18)F]-ADAM in a Parkinsonian Rat Model With Porcine Neural Xenografts |
| Q43076967 | Pharmacology of Rasagiline, a New MAO-B Inhibitor Drug for the Treatment of Parkinson's Disease with Neuroprotective Potential |
| Q60907864 | Regulation of dopamine neurotransmission from serotonergic neurons by ectopic expression of the dopamine D2 autoreceptor blocks levodopa-induced dyskinesia |
| Q31013566 | Serotonergic mechanisms in Parkinson's disease: opposing results from preclinical and clinical data |
| Q36680671 | Serotonin hyperinnervation and upregulated 5-HT2A receptor expression and motor-stimulating function in nigrostriatal dopamine-deficient Pitx3 mutant mice |
| Q37103028 | Striatal 5-HT1A receptor stimulation reduces D1 receptor-induced dyskinesia and improves movement in the hemiparkinsonian rat. |
| Q36852272 | The effects of BMY-14802 against L-DOPA- and dopamine agonist-induced dyskinesia in the hemiparkinsonian rat |
| Q37341623 | The role of the dorsal raphe nucleus in the development, expression, and treatment of L-dopa-induced dyskinesia in hemiparkinsonian rats |
| Q39289498 | The roles of striatal serotonin and L -amino-acid decarboxylase on L-DOPA-induced Dyskinesia in a Hemiparkinsonian rat model |
| Q28078271 | What Mechanisms Are Responsible for the Reuptake of Levodopa-Derived Dopamine in Parkinsonian Striatum? |
Search more.